Published in Kidney Int on February 11, 2009
Hepcidin and iron regulation, 10 years later. Blood (2011) 3.80
Hepcidin--a potential novel biomarker for iron status in chronic kidney disease. Clin J Am Soc Nephrol (2009) 2.61
Mechanisms of anemia in CKD. J Am Soc Nephrol (2012) 1.91
Iron sequestration and anemia of inflammation. Semin Hematol (2009) 1.85
The relation of hepcidin to iron disorders, inflammation and hemoglobin in chronic kidney disease. PLoS One (2014) 1.54
Targeting the hepcidin-ferroportin axis to develop new treatment strategies for anemia of chronic disease and anemia of inflammation. Am J Hematol (2012) 1.52
Results of the first international round robin for the quantification of urinary and plasma hepcidin assays: need for standardization. Haematologica (2009) 1.51
Treatment of chronic periodontitis decreases serum prohepcidin levels in patients with chronic kidney disease. Clinics (Sao Paulo) (2011) 1.50
Erythropoietin administration in humans causes a marked and prolonged reduction in circulating hepcidin. Haematologica (2009) 1.49
Molecular mechanisms of hepcidin regulation: implications for the anemia of CKD. Am J Kidney Dis (2010) 1.43
Manipulation of the hepcidin pathway for therapeutic purposes. Haematologica (2013) 1.32
Four-Week Studies of Oral Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor GSK1278863 for Treatment of Anemia. J Am Soc Nephrol (2015) 1.16
Evidence for a lack of a direct transcriptional suppression of the iron regulatory peptide hepcidin by hypoxia-inducible factors. PLoS One (2009) 1.10
Reduction of serum hepcidin by hemodialysis in pediatric and adult patients. Clin J Am Soc Nephrol (2010) 1.07
Targeting the hepcidin-ferroportin axis in the diagnosis and treatment of anemias. Adv Hematol (2009) 1.06
Immune dysfunction in uremia—an update. Toxins (Basel) (2012) 1.03
Evaluation of hepcidin isoforms in hemodialysis patients by a proteomic approach based on SELDI-TOF MS. J Biomed Biotechnol (2010) 0.99
Hepcidin levels in diabetes mellitus and polycystic ovary syndrome. Diabet Med (2013) 0.99
Hepcidin expression in anemia of chronic disease and concomitant iron-deficiency anemia. Clin Exp Med (2010) 0.95
The iron cycle in chronic kidney disease (CKD): from genetics and experimental models to CKD patients. Nephrol Dial Transplant (2013) 0.93
Hepcidin-25 in chronic hemodialysis patients is related to residual kidney function and not to treatment with erythropoiesis stimulating agents. PLoS One (2012) 0.92
HIF prolyl hydroxylase inhibitors for the treatment of renal anaemia and beyond. Nat Rev Nephrol (2015) 0.92
Inflammation-induced hepcidin-25 is associated with the development of anemia in septic patients: an observational study. Crit Care (2011) 0.88
A hepcidin lowering agent mobilizes iron for incorporation into red blood cells in an adenine-induced kidney disease model of anemia in rats. Nephrol Dial Transplant (2013) 0.88
Tubular reabsorption and local production of urine hepcidin-25. BMC Nephrol (2013) 0.87
Unexplained aspects of anemia of inflammation. Adv Hematol (2010) 0.87
Is hepcidin the star player in iron metabolism in chronic kidney disease? Kidney Int (2009) 0.85
Iron-refractory iron deficiency anemia: new molecular mechanisms. Kidney Int (2009) 0.85
Plasma hepcidin levels and anemia in old age. The Leiden 85-Plus Study. Haematologica (2012) 0.83
Iron dosing in kidney disease: inconsistency of evidence and clinical practice. Nephrol Dial Transplant (2014) 0.81
Hepcidin and risk of anemia in CKD: a cross-sectional and longitudinal analysis in the CKiD cohort. Pediatr Nephrol (2014) 0.81
Serum hepcidin levels and reticulocyte hemoglobin concentrations as indicators of the iron status of peritoneal dialysis patients. Int J Nephrol (2012) 0.81
Hepcidin in anemia of chronic kidney disease: review for the pediatric nephrologist. Pediatr Nephrol (2011) 0.80
A novel monoclonal antibody immunoassay for the detection of human serum hepcidin. J Gastroenterol (2010) 0.80
Regulation of Hepcidin-25 by Short- and Long-Acting rhEPO May Be Dependent on Ferritin and Predict the Response to rhEPO in Hemodialysis Patients. Nephron Extra (2014) 0.79
Serum prohepcidin levels are potential prognostic markers in patients with multiple myeloma. Exp Ther Med (2012) 0.79
A 3-marker index improves the identification of iron disorders in CKD anaemia. PLoS One (2014) 0.79
Hepcidin levels in patients with renal disease. Kidney Int (2009) 0.78
Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease. Kidney Int (2009) 0.78
Understanding and exploiting hepcidin as an indicator of anemia due to chronic kidney disease. Kidney Res Clin Pract (2013) 0.77
The utility of multivariate analysis in the study of hepcidin. Kidney Int (2009) 0.77
Hepcidin-25 in diabetic chronic kidney disease is predictive for mortality and progression to end stage renal disease. PLoS One (2015) 0.77
Potential effects of omega-3 fatty acids on anemia and inflammatory markers in maintenance hemodialysis patients. Daru (2014) 0.76
Laboratory use of hepcidin in renal transplant recipients. Biochem Med (Zagreb) (2016) 0.76
Correction of iron deficiency in the cardiorenal syndrome. Int J Nephrol (2011) 0.76
Can Serum Gdf-15 be Associated with Functional Iron Deficiency in Hemodialysis Patients? Indian J Hematol Blood Transfus (2015) 0.75
Hepcidin Response to Iron Therapy in Patients with Non-Dialysis Dependent CKD: An Analysis of the FIND-CKD Trial. PLoS One (2016) 0.75
Effects of dietary iron intake and chronic kidney disease on fibroblast growth factor 23 metabolism in wild-type and hepcidin knockout mice. Am J Physiol Renal Physiol (2016) 0.75
The relationship between anemia, liver disease, and hepcidin levels in hemodialysis patients with hepatitis. Indian J Nephrol (2012) 0.75
Study of anemia in nondialysis dependent chronic kidney disease with special reference to serum hepcidin. Indian J Nephrol (2017) 0.75
Does erythropoietin cause hemoglobin variability--is it 'normal'? PLoS One (2014) 0.75
Hemodiafiltration improves plasma 25-hepcidin levels: a prospective, randomized, blinded, cross-over study comparing hemodialysis and hemodiafiltration. Nephron Extra (2012) 0.75
Hepcidin-25 negatively predicts left ventricular mass index in chronic kidney disease patients. World J Nephrol (2013) 0.75
Relationship between hepcidin and ferritin in haemodialysed patients. Wien Klin Wochenschr (2013) 0.75
Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet (2008) 13.15
Gut hormone PYY(3-36) physiologically inhibits food intake. Nature (2002) 8.30
Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma. Mol Cell Biol (2005) 6.44
Inhibition of food intake in obese subjects by peptide YY3-36. N Engl J Med (2003) 5.83
HIF activation identifies early lesions in VHL kidneys: evidence for site-specific tumor suppressor function in the nephron. Cancer Cell (2002) 4.82
Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg (2006) 4.30
Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia. Nat Genet (2002) 4.06
AMP-activated protein kinase plays a role in the control of food intake. J Biol Chem (2004) 3.84
Widespread hypoxia-inducible expression of HIF-2alpha in distinct cell populations of different organs. FASEB J (2002) 3.81
Structural basis for the recognition of hydroxyproline in HIF-1 alpha by pVHL. Nature (2002) 3.78
Genetic loci influencing kidney function and chronic kidney disease. Nat Genet (2010) 3.75
Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis. Lancet (2010) 3.74
Metabolic surgery profoundly influences gut microbial-host metabolic cross-talk. Gut (2011) 3.42
Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids. Ann Rheum Dis (2013) 3.39
Expression of hypoxia-inducible factor-1alpha and -2alpha in hypoxic and ischemic rat kidneys. J Am Soc Nephrol (2002) 3.34
Kisspeptin-54 stimulates the hypothalamic-pituitary gonadal axis in human males. J Clin Endocrinol Metab (2005) 3.08
Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass. Ann Surg (2007) 3.02
Renal cyst formation in Fh1-deficient mice is independent of the Hif/Phd pathway: roles for fumarate in KEAP1 succination and Nrf2 signaling. Cancer Cell (2011) 3.00
A family with erythrocytosis establishes a role for prolyl hydroxylase domain protein 2 in oxygen homeostasis. Proc Natl Acad Sci U S A (2006) 2.90
C3 glomerulopathy: consensus report. Kidney Int (2013) 2.85
Snail activation disrupts tissue homeostasis and induces fibrosis in the adult kidney. EMBO J (2006) 2.80
Parkin protects against the toxicity associated with mutant alpha-synuclein: proteasome dysfunction selectively affects catecholaminergic neurons. Neuron (2002) 2.65
Gut hormones and the regulation of energy homeostasis. Nature (2006) 2.53
Expression of hypoxia-inducible factors in human renal cancer: relationship to angiogenesis and to the von Hippel-Lindau gene mutation. Cancer Res (2002) 2.31
Regulation of E-cadherin expression by VHL and hypoxia-inducible factor. Cancer Res (2006) 2.24
Genome-wide association study identifies variants in TMPRSS6 associated with hemoglobin levels. Nat Genet (2009) 2.19
The inhibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway. Brain Res (2005) 2.19
Venular basement membranes contain specific matrix protein low expression regions that act as exit points for emigrating neutrophils. J Exp Med (2006) 2.13
Post-embryonic ablation of AgRP neurons in mice leads to a lean, hypophagic phenotype. FASEB J (2005) 2.03
Heterozygous deficiency of hypoxia-inducible factor-2alpha protects mice against pulmonary hypertension and right ventricular dysfunction during prolonged hypoxia. J Clin Invest (2003) 2.00
Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trial. J Clin Endocrinol Metab (2004) 1.97
Genetic evidence for a tumor suppressor role of HIF-2alpha. Cancer Cell (2005) 1.89
Gastric bypass increases energy expenditure in rats. Gastroenterology (2009) 1.79
Sustained appetite improvement in malnourished dialysis patients by daily ghrelin treatment. Kidney Int (2009) 1.78
An increase in kisspeptin-54 release occurs with the pubertal increase in luteinizing hormone-releasing hormone-1 release in the stalk-median eminence of female rhesus monkeys in vivo. Endocrinology (2008) 1.76
The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control. Endocrinology (2012) 1.70
Cardiac survival after pre-emptive coronary angiography in transplant patients and those awaiting transplantation. Clin J Am Soc Nephrol (2011) 1.70
Inhibition of hypoxia inducible factor hydroxylases protects against renal ischemia-reperfusion injury. J Am Soc Nephrol (2008) 1.68
Familial C3 glomerulopathy associated with CFHR5 mutations: clinical characteristics of 91 patients in 16 pedigrees. Clin J Am Soc Nephrol (2011) 1.66
Mutation of von Hippel-Lindau tumour suppressor and human cardiopulmonary physiology. PLoS Med (2006) 1.66
Loss of prolyl hydroxylase-1 protects against colitis through reduced epithelial cell apoptosis and increased barrier function. Gastroenterology (2010) 1.64
HLA has strongest association with IgA nephropathy in genome-wide analysis. J Am Soc Nephrol (2010) 1.64
Effect of bariatric surgery-induced weight loss on renal and systemic inflammation and blood pressure: a 12-month prospective study. Surg Obes Relat Dis (2012) 1.62
Abnormal sympathoadrenal development and systemic hypotension in PHD3-/- mice. Mol Cell Biol (2008) 1.62
Effects of exercise on gut peptides, energy intake and appetite. J Endocrinol (2007) 1.61
Kisspeptin-54 triggers egg maturation in women undergoing in vitro fertilization. J Clin Invest (2014) 1.58
The A20 gene protects kidneys from ischaemia/reperfusion injury by suppressing pro-inflammatory activation. J Mol Med (Berl) (2008) 1.58
Survival and death signals can predict tumor response to therapy after oncogene inactivation. Sci Transl Med (2011) 1.56
Deletion of the von Hippel-Lindau gene in pancreatic beta cells impairs glucose homeostasis in mice. J Clin Invest (2008) 1.56
Subcutaneous oxyntomodulin reduces body weight in overweight and obese subjects: a double-blind, randomized, controlled trial. Diabetes (2005) 1.52
Results of the first international round robin for the quantification of urinary and plasma hepcidin assays: need for standardization. Haematologica (2009) 1.51
Erythropoietin administration in humans causes a marked and prolonged reduction in circulating hepcidin. Haematologica (2009) 1.49
Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively. Endocrinology (2005) 1.49
Assessing glycemic control in maintenance hemodialysis patients with type 2 diabetes. Diabetes Care (2009) 1.49
Neuropeptide S stimulates the hypothalamo-pituitary-adrenal axis and inhibits food intake. Endocrinology (2006) 1.49
Tumor cell plasticity in Ewing sarcoma, an alternative circulatory system stimulated by hypoxia. Cancer Res (2005) 1.49
Iron deficiency and raised hepcidin in idiopathic pulmonary arterial hypertension: clinical prevalence, outcomes, and mechanistic insights. J Am Coll Cardiol (2011) 1.48
Improved diagnostic accuracy for neuroendocrine neoplasms using two chromogranin A assays. Clin Endocrinol (Oxf) (2012) 1.47
Kisspeptin-54 stimulates gonadotropin release most potently during the preovulatory phase of the menstrual cycle in women. J Clin Endocrinol Metab (2007) 1.46
Gastric bypass reduces fat intake and preference. Am J Physiol Regul Integr Comp Physiol (2011) 1.44
Prolyl hydroxylase 3 (PHD3) is essential for hypoxic regulation of neutrophilic inflammation in humans and mice. J Clin Invest (2011) 1.44
The von Hippel-Lindau tumor suppressor protein and Egl-9-Type proline hydroxylases regulate the large subunit of RNA polymerase II in response to oxidative stress. Mol Cell Biol (2008) 1.43
Xenon preconditioning protects against renal ischemic-reperfusion injury via HIF-1alpha activation. J Am Soc Nephrol (2009) 1.43
Formation of primary cilia in the renal epithelium is regulated by the von Hippel-Lindau tumor suppressor protein. J Am Soc Nephrol (2006) 1.42
The use of the Pain Assessment Checklist for Seniors with Limited Ability to Communicate (PACSLAC) by caregivers in dementia care. N Z Med J (2008) 1.42
Remission of type 2 diabetes after gastric bypass and banding: mechanisms and 2 year outcomes. Ann Surg (2010) 1.39
Ghrelin, peptide YY, glucose-dependent insulinotropic polypeptide, and hunger responses to a mixed meal in anorexic, obese, and control female adolescents. J Clin Endocrinol Metab (2005) 1.38
Can we develop a Canadian Perioperative Anesthesiology Clinical Trials group? Can J Anaesth (2010) 1.38
Gut peptides in the regulation of food intake and energy homeostasis. Endocr Rev (2006) 1.38
Subcutaneous injection of kisspeptin-54 acutely stimulates gonadotropin secretion in women with hypothalamic amenorrhea, but chronic administration causes tachyphylaxis. J Clin Endocrinol Metab (2009) 1.38
Autosomal dominant erythrocytosis and pulmonary arterial hypertension associated with an activating HIF2 alpha mutation. Blood (2008) 1.37
Oxyntomodulin suppresses appetite and reduces food intake in humans. J Clin Endocrinol Metab (2003) 1.35
The gut hormones PYY 3-36 and GLP-1 7-36 amide reduce food intake and modulate brain activity in appetite centers in humans. Cell Metab (2011) 1.35
Leptin inhibits the anti-CD3-driven proliferation of peripheral blood T cells but enhances the production of proinflammatory cytokines. J Leukoc Biol (2002) 1.33
Gut hypertrophy after gastric bypass is associated with increased glucagon-like peptide 2 and intestinal crypt cell proliferation. Ann Surg (2010) 1.32
Peripheral oxyntomodulin reduces food intake and body weight gain in rats. Endocrinology (2004) 1.31